Nimbleheart, Inc.
NimbleHeart is dedicated to reimagining preventive cardiac monitoring through innovative wearable exercise ECG technology. Their FDA cleared and patented dry electrode system offers a comfortable, reusable, and non-invasive solution for primary and secondary preventive care, including remote monitoring and cardiac screening. Recognized for their leadership in cardiac monitoring, NimbleHeart collaborates with NASA, medical societies, and industry partners to advance cardiac health and early detection of heart conditions.
Industries
Nr. of Employees
small (1-50)
Patents
System, software and method of streaming ECG/EKG data over bluetooth low-energy interface
US-10105054-B2
View Details
System, software and method of streaming ECG/EKG data over bluetooth low-energy interface
US-10105054-B2
View DetailsProducts
One-lead wearable telemetry monitor (reusable dry-electrode)
A wearable one-lead outpatient ECG telemetry harness incorporating three dry electrodes, embedded ECG acquisition electronics and BLE interface to mobile platforms for live clinical-grade ECG streaming, intended for exercise monitoring and remote screening.
3-lead wearable ECG harness with embedded acquisition
A multi-lead (three-lead) wearable harness with built-in ECG acquisition electronics and BLE interface for continuous clinical-grade ECG capture intended for real-time or post-record interpretation; planned for market pending regulatory clearance.
12-lead wearable ECG harness (third-party acquisition compatible)
A 12-lead wearable harness designed to connect to external ECG acquisition hardware, enabling multi-lead exercise and ambulatory ECG assessments without adhesive electrodes.
One-lead wearable telemetry monitor (reusable dry-electrode)
A wearable one-lead outpatient ECG telemetry harness incorporating three dry electrodes, embedded ECG acquisition electronics and BLE interface to mobile platforms for live clinical-grade ECG streaming, intended for exercise monitoring and remote screening.
3-lead wearable ECG harness with embedded acquisition
A multi-lead (three-lead) wearable harness with built-in ECG acquisition electronics and BLE interface for continuous clinical-grade ECG capture intended for real-time or post-record interpretation; planned for market pending regulatory clearance.
12-lead wearable ECG harness (third-party acquisition compatible)
A 12-lead wearable harness designed to connect to external ECG acquisition hardware, enabling multi-lead exercise and ambulatory ECG assessments without adhesive electrodes.
Services
Clinical screening service for symptom-free and at-risk individuals using wearable exercise ECG harnesses with clinical review and a report including METS, exercise recommendations, heart rate zones and cardiac risk assessment.
Telemetry-enabled solution to support virtual or hybrid cardiac rehabilitation programs, delivering live ECG and heart rate monitoring to clinicians via mobile apps and a secure cloud portal.
Clinical screening service for symptom-free and at-risk individuals using wearable exercise ECG harnesses with clinical review and a report including METS, exercise recommendations, heart rate zones and cardiac risk assessment.
Telemetry-enabled solution to support virtual or hybrid cardiac rehabilitation programs, delivering live ECG and heart rate monitoring to clinicians via mobile apps and a secure cloud portal.
Expertise Areas
- Wearable cardiac monitoring
- Exercise ECG telemetry
- Preventive cardiac screening
- Remote/home cardiac rehabilitation
Key Technologies
- Dry-contact electrodes (no-gel, reusable)
- Wearable harness ECG form factors (one-lead to 12-lead harnesses)
- Bluetooth Low Energy ECG streaming
- Embedded multichannel ECG acquisition
News & Updates
In September 2024, NimbleHeart launched a preventive cardiac screening program using monitored exercise testing for individuals with cardiac risk, offered in-person or remotely.
In June 2024, NimbleHeart received a patent from the Government of India for 'Method and Apparatus for Motion Artifact reduction in ECG harness'.
In November 2023, NimbleHeart was recognized as a top global innovator of Indian origin for its FDA cleared patented ambulatory outpatient wearable ECG technology.
NimbleHeart was selected as a TiE50 Winner at TiEcon 2016, a major entrepreneurial conference.
Recognized as a top 5 finalist at the American Heart Association Scientific Session for its innovative technology.
In September 2024, NimbleHeart launched a preventive cardiac screening program using monitored exercise testing for individuals with cardiac risk, offered in-person or remotely.
In June 2024, NimbleHeart received a patent from the Government of India for 'Method and Apparatus for Motion Artifact reduction in ECG harness'.
In November 2023, NimbleHeart was recognized as a top global innovator of Indian origin for its FDA cleared patented ambulatory outpatient wearable ECG technology.
NimbleHeart was selected as a TiE50 Winner at TiEcon 2016, a major entrepreneurial conference.
Recognized as a top 5 finalist at the American Heart Association Scientific Session for its innovative technology.